Tom Wilemon

June 6, 2019

Immunotherapy helping 87-year-old man stay on the job

Nine years after being diagnosed with metastatic lung cancer, Roszell Mack Jr., 87, still goes into the office every day thanks to a durable response to the immunotherapy pembrolizumab.

By Tom Wilemon
May 3, 2019

Bioimpedance spectroscopy better than tape measure for identifying lymphedema risk

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema.

By Tom Wilemon
April 22, 2019

Cancer Center’s annual scientific retreat set for May 1

The varying roles that signaling molecules play in progression of cancer is the focus of the Vanderbilt-Ingram Cancer Center 20th Annual Scientific Retreat when some of the nation’s top experts will speak about “Signal Transduction in Cancer Initiation, Progression and Treatment.”

By Tom Wilemon
April 19, 2019

Doctor and patient compete for honor

By Tom Wilemon
From left, Wei Zheng, MD, PhD, Jae Jeong Yang, PhD, Danxia Yu, PhD, and colleagues are studying smoking patterns and associated deaths in Asian countries.
April 18, 2019

Asian nations in early tobacco epidemic: study

Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases.

By Tom Wilemon
The Vanderbilt team studying histoplasmosis includes (front row, from left, Heidi Chen, PhD, Melinda Aldrich, PhD, MPH, (back row, from left) Stephen Deppen, PhD, Eric Grogan, MD, MPH, and Jeffrey Blume, PhD.
April 18, 2019

Team explores fungal infection quandary in lung cancer screenings

Serving a region that lies within the tobacco belt, clinicians at Vanderbilt Health face challenges distinguishing lung cancer from histoplasmosis, a fungal infection that creates cancer-mimicking lesions in the lungs.

By Tom Wilemon
April 11, 2019

Study reframes approach to targeted therapy resistance

When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.
By Tom Wilemon
April 4, 2019

Head and neck cancer screening event set for April 12

Early diagnosis of head and neck cancer greatly increases odds of survival, but its symptoms can be subtle or mimic viral infections, so Vanderbilt Health offers a free screening annually.
By Tom Wilemon
March 28, 2019

Hot chemotherapy surgery helps save patient’s leg

Tom Deweese can keep up with his grandchildren because of a highly specialized surgery using hot chemotherapy that saved his leg.
By Tom Wilemon
March 25, 2019

Ten years ago, Mike Lavin was saved by a bone marrow transplant. A few days ago, he paid a surprise visit to the donor who made it possible.

“I really appreciate everything you have done. I’m here because of you.”
By Tom Wilemon
March 14, 2019

Cancer Center Ambassadors surpass $1 million in grants

Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.
By Tom Wilemon
February 28, 2019

Investigators map genomic landscape of very rare cancer

A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
By Tom Wilemon
1 … 24 25 26 27 28 … 39